Nikiphorou E, Ramiro S, Van Der Heijde D, Norton S, Moltó A, Dougados M, Van Den Bosch F, Landewé R, the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study Task Force (2018) Association of Comorbidities in Spondyloarthritis with poor function, work disability, and quality of life: results from the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study. Arthritis Care Res 70:1257–1262. https://doi.org/10.1002/acr.23468

Article  CAS  Google Scholar 

Norton S, Koduri G, Nikiphorou E, Dixey J, Williams P, Young A (2013) A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology 52:99–110. https://doi.org/10.1093/rheumatology/kes262

Article  PubMed  Google Scholar 

McPhail S (2016) Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy Volume 9:143–156. https://doi.org/10.2147/RMHP.S97248

Article  Google Scholar 

Radner H, Yoshida K, Frits M, Iannaccone C, Shadick NA, Weinblatt M, Smolen JS, Solomon DH (2015) The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs. Rheumatology 54:2076–2084. https://doi.org/10.1093/rheumatology/kev239

Article  CAS  PubMed  Google Scholar 

Haroon NN, Paterson JM, Li P, Inman RD, Haroon N (2015) Patients with Ankylosing Spondylitis have increased Cardiovascular and Cerebrovascular Mortality: a Population-based study. Ann Intern Med 163:409–416. https://doi.org/10.7326/M14-2470

Article  PubMed  Google Scholar 

Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, Mason JC, Rahimi K, McMurray JJV, Verbakel JY (2022) Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet 400:733–743. https://doi.org/10.1016/S0140-6736(22)01349-6

Article  PubMed  Google Scholar 

Hintenberger R, Affenzeller B, Vladychuk V, Pieringer H (2023) Cardiovascular risk in axial spondyloarthritis-a systematic review. Clin Rheumatol 42:2621–2633. https://doi.org/10.1007/s10067-023-06655-z

Article  PubMed  PubMed Central  Google Scholar 

Mendoza Pinto C, Munguía-Realpozo P, Etchegaray-Morales I, García-Carrasco M, Méndez Martínez S (2023) Risk of Diabetes Mellitus in Systemic Lupus Erythematosus: Systematic Review and Meta-analysis. Arthritis Rheumatol

Tian Z, Mclaughlin J, Verma A, Chinoy H, Heald AH (2021) The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Endocrinol Metab 10:125–131. https://doi.org/10.1097/XCE.0000000000000244

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H-H, Yeh S-Y, Chen H-Y, Lin C-L, Sung F-C, Kao C-H (2014) Ankylosing spondylitis and other inflammatory spondyloarthritis increase the risk of developing type 2 diabetes in an Asian population. Rheumatol Int 34:265–270. https://doi.org/10.1007/s00296-013-2927-5

Article  CAS  PubMed  Google Scholar 

Zhao SS, Radner H, Siebert S, Duffield SJ, Thong D, Hughes DM, Moots RJ, Solomon DH, Goodson NJ (2019) Comorbidity burden in axial spondyloarthritis: a cluster analysis. Rheumatology 58:1746–1754. https://doi.org/10.1093/rheumatology/kez119

Article  PubMed  PubMed Central  Google Scholar 

Jothimurugan S, Byravan S, Moorthy A (2022) Is there an increased prevalence of diabetes mellitus in the axial spondyloarthritis patient group: a review from a UK teaching hospital spondyloarthropathy service. Ann Rheum Dis 81:18252–11826. https://doi.org/10.1136/annrheumdis-2022-eular.2463

Article  Google Scholar 

Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ (2020) Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology 59:iv47–iv57. https://doi.org/10.1093/rheumatology/keaa246

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ n71. https://doi.org/10.1136/bmj.n71

Article  Google Scholar 

Kelley GA, Kelley KS (2023) Evolution of statistical models for meta-analysis and implications for best practice. Curr Opin Epidemiol Public Health 2:39–44. https://doi.org/10.1097/PXH.0000000000000023

Article  Google Scholar 

IntHout J, Ioannidis JPA, Rovers MM, Goeman JJ (2016) Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open 6:e010247. https://doi.org/10.1136/bmjopen-2015-010247

Article  PubMed  PubMed Central  Google Scholar 

Çay HF, Alkan Melikoğlu M, Gül Yurdakul F, Bodur H, Ataman Ş, Çapkın E, Gürer G, Sezer İ, Duruöz MT, Rezvani A, Yağcı İ, Göğüş F, Kamanli A, Çevik R, Akgül Ö (2023) Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar. Arch Rheumatol 38:333–346. https://doi.org/10.46497/ArchRheumatol.2023.9793

Article  PubMed  Google Scholar 

Dregan A, Chowienczyk P, Molokhia M (2017) Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders. Heart 103:1867–1873. https://doi.org/10.1136/heartjnl-2017-311214

Article  PubMed  Google Scholar 

Gherghe AM, Dougados M, Combe B, Landewé R, Mihai C, Berenbaum F, Mariette X, Wolterbeek R, Van Der Heijde D (2015) Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts. RMD Open 1:e000128. https://doi.org/10.1136/rmdopen-2015-000128

Article  PubMed  PubMed Central  Google Scholar 

Landgren AJ, Dehlin M, Jacobsson L, Bergsten U, Klingberg E (2021) Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden. RMD Open 7:e001568. https://doi.org/10.1136/rmdopen-2021-001568

Article  PubMed  PubMed Central  Google Scholar 

Redeker I, Callhoff J, Hoffmann F, Marschall U, Haibel H, Sieper J, Zink A, Poddubnyy D (2020) The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study. Arthritis Res Ther 22:210. https://doi.org/10.1186/s13075-020-02301-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wibetoe G, Ikdahl E, Rollefstad S, Olsen IC, Bergsmark K, Kvien TK, Salberg A, Soldal DM, Bakland G, Lexberg Å, Fevang B-T, Gulseth HC, Haugeberg G, Semb AG (2017) Cardiovascular disease risk profiles in inflammatory joint disease entities. Arthritis Res Ther 19:153. https://doi.org/10.1186/s13075-017-1358-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yilmaz E, Eren O (2023) The frequency of atopic diseases and metabolic conditions in patients with Ankylosing spondylitis: a cross-sectional clinical trial with a review of literature. https://doi.org/10.1055/a-2018-3568. Aktuelle Rheumatol a-2018-3568

Zabotti A, Luchetti MM, Selmi CF, Ramonda R, Grembiale RD, Dagna L, D’Angelo S, Cafaro G, De Vita S, Felicetti M, Marelli S, Frigerio D, Favalli EG (2021) An Italian disease-based Registry of Axial and Peripheral spondyloarthritis: the SIRENA Study. Front Med 8:711875. https://doi.org/10.3389/fmed.2021.711875

Article  Google Scholar 

Ziade N, El Khoury B, Zoghbi M, Merheb G, Abi Karam G, Mroue’ K, Messaykeh J (2020) Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study. Sci Rep 10:7683. https://doi.org/10.1038/s41598-020-64732-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmed N, Prior JA, Chen Y, Hayward R, Mallen CD, Hider SL (2016) Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study. Clin Rheumatol 35:3069–3073. https://doi.org/10.1007/s10067-016-3362-2

Article  PubMed  Google Scholar 

Brophy S, Cooksey R, Atkinson M, Zhou S-M, Husain MJ, Macey S, Rahman MA, Siebert S (2012) No increased rate of Acute myocardial infarction or stroke among patients with Ankylosing Spondylitis—A Retrospective Cohort Study using Routine Data. Semin Arthritis Rheum 42:140–145. https://doi.org/10.1016/j.semarthrit.2012.02.008

Article  PubMed  Google Scholar 

Cook MJ, Bellou E, Bowes J, Sergeant JC, O’Neill TW, Barton A, Verstappen SMM (2018) The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank. Rheumatology 57:2172–2182. https://doi.org/10.1093/rheumatology/key224

Article  PubMed  PubMed Central  Google Scholar 

Han C, Robinson DW, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172

PubMed